Buy Blueprint Medicines Stock | BPMC Stock Price & Latest News | Public
BPMC

Blueprint Medicines

$0.00 (0.00%)Today

    About BPMC

    Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alex...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    11.16
    6.68
    2.2
    -2.28
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$1.72

    Actual EPS
    Q4 2020

    Stats

    Market Cap$5,97B
    Volume26,66k
    Price-to-Earnings Ratio19.75
    Dividend Rate
    Dividend Yield
    1 Year High$108.50
    1 Year Low$43.29
    Open$108.50
    High$109.32
    Low$104.25

    Buy any stock with any amount of money.

    Download the App
    Download the app